share_log

B of A Securities Initiates Coverage On Sutro Biopharma With Buy Rating, Announces Price Target of $12

B of A Securities Initiates Coverage On Sutro Biopharma With Buy Rating, Announces Price Target of $12

B of A Securities以买入评级启动对Sutro Biopharma的报道,宣布目标股价为12美元
Benzinga ·  05/08 06:16

B of A Securities analyst Tazeen Ahmad initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and announces Price Target of $12.

B of A Securities分析师塔泽恩·艾哈迈德以买入评级启动了对Sutro Biopharma(纳斯达克股票代码:STRO)的报道,并宣布目标股价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发